National audit of epistaxis management

Hopkins, Claire; Fishman, Jonathan; Youngs, Robin; Fisher, Edward; Hussain, Musheer

doi:10.1017/s0022215117002419

J. Laryngol. Otol.

2017

DOI: 10.1017/s0022215117002419

|View full text |Cite

National audit of epistaxis management

Claire Hopkins¹,

Jonathan Fishman²,

Robin Youngs³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

2021

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The highlight in this month's issue is another excellent paper from the Integrate team investigating mortality following epistaxis 1 . This recent article follows the success of Integrate's national epistaxis and peritonsillar abscess audits, previously published in The Journal 2 – 6…”

mentioning

confidence: 92%

Epistaxis audit revisited

Fishman¹,

Fisher²,

Hussain³

2018

J. Laryngol. Otol.

Self Cite

View full text Add to dashboard Cite

Integrate team investigating mortality following epistaxis. 1 This recent article follows the success of Integrate's national epistaxis and peritonsillar abscess audits, previously published in The Journal. 2-6 The 'Epistaxis 2016: national audit of management' collected prospective data over a 30-day audit window in 113 centres. A higher than expected 30-day all-cause mortality rate of 3.4 per cent was identified in the audit. In this recent article, the study examines in more detail the subgroup of patients who died during the audit period. In their analysis, the authors found that patients who died were more likely to: come from a ward environment; have co-existing cardiovascular disease, diabetes or a bleeding diathesis; be on antithrombotic medication; or have received a blood transfusion. Patients did not die from exsanguination. The authors therefore concluded that epistaxis may be seen as a general marker of poor health and a poor prognostic sign in otherwise already morbid patients. Nevertheless, the aforementioned risk factors should serve as red-flag features associated with higher mortality in epistaxis patients.

show abstract

mentioning

confidence: 92%

Epistaxis audit revisited

Fishman¹,

Fisher²,

Hussain³

2018

J. Laryngol. Otol.

Self Cite

View full text Add to dashboard Cite

show abstract

Evaluating the efficacy of Achillea Millefolium ointment in the treatment of recurrent idiopathic epistaxis; a randomized double-blind clinical trial

Hashemian

Akbarpour

Razaghi³

et al. 2021

Journal of Herbal Medicine

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

National audit of epistaxis management

Cited by 2 publications

References 5 publications

Epistaxis audit revisited

Epistaxis audit revisited

Evaluating the efficacy of Achillea Millefolium ointment in the treatment of recurrent idiopathic epistaxis; a randomized double-blind clinical trial

Contact Info

Product

Resources

About